Johannes Fruehauf, MD, PhD
CEO, Cambridge Biolabs and ViThera Pharma; Cofounder, Cequent Pharmaceuticals
Johannes Fruehauf is a founder and the president and executive director of LabCentral. He is responsible for all aspects of LabCentral’s operation. Johannes is a physician and successful biotech entrepreneur. Prior to LabCentral, he founded Cambridge Biolabs, a contract research facility serving startup and virtual companies in Kendall Square. He is also a co-founder of ViThera Pharmaceuticals, Deltix and Cequent Pharmaceuticals, and an advisor or board member to numerous life sciences companies and non-profits. Johannes earned his medical degree at the University of Frankfurt and his PhD at the University of Heidelberg (Germany).
Favorite school science project: “Anything that would explode! Electrolytic preparation of oxyhydrogen and I also built cannons with black powder.”